vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and Thermon Group Holdings, Inc. (THR). Click either name above to swap in a different company.

Thermon Group Holdings, Inc. is the larger business by last-quarter revenue ($147.3M vs $76.4M, roughly 1.9× PROCEPT BioRobotics Corp). Thermon Group Holdings, Inc. runs the higher net margin — 12.4% vs -39.1%, a 51.5% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (11.9% vs 9.6%). Thermon Group Holdings, Inc. produced more free cash flow last quarter ($13.1M vs $-12.2M).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Thermon Group Holdings, Inc. is a global provider of engineered thermal management solutions, specializing in heat tracing systems, heating cables, temperature monitoring controls, and associated installation support services. It serves core industrial segments including oil and gas, chemical processing, power generation, and food and beverage, with operating bases across North America, Europe, Asia-Pacific, and Latin America.

PRCT vs THR — Head-to-Head

Bigger by revenue
THR
THR
1.9× larger
THR
$147.3M
$76.4M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+2.3% gap
PRCT
11.9%
9.6%
THR
Higher net margin
THR
THR
51.5% more per $
THR
12.4%
-39.1%
PRCT
More free cash flow
THR
THR
$25.2M more FCF
THR
$13.1M
$-12.2M
PRCT

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
PRCT
PRCT
THR
THR
Revenue
$76.4M
$147.3M
Net Profit
$-29.8M
$18.3M
Gross Margin
60.6%
46.6%
Operating Margin
-40.6%
18.1%
Net Margin
-39.1%
12.4%
Revenue YoY
11.9%
9.6%
Net Profit YoY
-58.3%
-1.3%
EPS (diluted)
$-0.54
$0.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
THR
THR
Q4 25
$76.4M
$147.3M
Q3 25
$83.3M
$131.7M
Q2 25
$79.2M
$108.9M
Q1 25
$69.2M
Q4 24
$68.2M
Q3 24
$58.4M
Q2 24
$53.4M
Q1 24
$44.5M
Net Profit
PRCT
PRCT
THR
THR
Q4 25
$-29.8M
$18.3M
Q3 25
$-21.4M
$15.0M
Q2 25
$-19.6M
$8.6M
Q1 25
$-24.7M
Q4 24
$-18.9M
Q3 24
$-21.0M
Q2 24
$-25.6M
Q1 24
$-26.0M
Gross Margin
PRCT
PRCT
THR
THR
Q4 25
60.6%
46.6%
Q3 25
64.8%
46.4%
Q2 25
65.4%
44.1%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Q1 24
56.2%
Operating Margin
PRCT
PRCT
THR
THR
Q4 25
-40.6%
18.1%
Q3 25
-27.8%
16.4%
Q2 25
-28.0%
10.8%
Q1 25
-39.7%
Q4 24
-28.9%
Q3 24
-38.4%
Q2 24
-50.3%
Q1 24
-62.1%
Net Margin
PRCT
PRCT
THR
THR
Q4 25
-39.1%
12.4%
Q3 25
-25.7%
11.4%
Q2 25
-24.7%
7.9%
Q1 25
-35.8%
Q4 24
-27.6%
Q3 24
-35.9%
Q2 24
-48.0%
Q1 24
-58.3%
EPS (diluted)
PRCT
PRCT
THR
THR
Q4 25
$-0.54
$0.55
Q3 25
$-0.38
$0.45
Q2 25
$-0.35
$0.26
Q1 25
$-0.45
Q4 24
$-0.34
Q3 24
$-0.40
Q2 24
$-0.50
Q1 24
$-0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
THR
THR
Cash + ST InvestmentsLiquidity on hand
$286.5M
$46.9M
Total DebtLower is stronger
$51.6M
Stockholders' EquityBook value
$365.9M
$538.7M
Total Assets
$508.1M
$816.7M
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
THR
THR
Q4 25
$286.5M
$46.9M
Q3 25
$294.3M
$29.7M
Q2 25
$302.7M
$36.5M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Q1 24
$225.6M
Total Debt
PRCT
PRCT
THR
THR
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Q1 24
$51.4M
Stockholders' Equity
PRCT
PRCT
THR
THR
Q4 25
$365.9M
$538.7M
Q3 25
$380.3M
$515.2M
Q2 25
$385.8M
$509.3M
Q1 25
$389.2M
Q4 24
$402.2M
Q3 24
$241.2M
Q2 24
$251.8M
Q1 24
$264.0M
Total Assets
PRCT
PRCT
THR
THR
Q4 25
$508.1M
$816.7M
Q3 25
$511.5M
$778.2M
Q2 25
$513.1M
$765.3M
Q1 25
$519.4M
Q4 24
$534.0M
Q3 24
$374.1M
Q2 24
$374.4M
Q1 24
$382.9M
Debt / Equity
PRCT
PRCT
THR
THR
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×
Q1 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
THR
THR
Operating Cash FlowLast quarter
$-10.3M
$18.0M
Free Cash FlowOCF − Capex
$-12.2M
$13.1M
FCF MarginFCF / Revenue
-15.9%
8.9%
Capex IntensityCapex / Revenue
2.4%
3.3%
Cash ConversionOCF / Net Profit
0.98×
TTM Free Cash FlowTrailing 4 quarters
$-58.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
THR
THR
Q4 25
$-10.3M
$18.0M
Q3 25
$-6.6M
$7.4M
Q2 25
$-15.0M
$10.7M
Q1 25
$-17.0M
Q4 24
$-32.4M
Q3 24
$-18.8M
Q2 24
$-15.7M
Q1 24
$-32.3M
Free Cash Flow
PRCT
PRCT
THR
THR
Q4 25
$-12.2M
$13.1M
Q3 25
$-9.5M
$4.4M
Q2 25
$-17.8M
$8.3M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
Q1 24
$-34.2M
FCF Margin
PRCT
PRCT
THR
THR
Q4 25
-15.9%
8.9%
Q3 25
-11.4%
3.3%
Q2 25
-22.5%
7.6%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Q1 24
-76.9%
Capex Intensity
PRCT
PRCT
THR
THR
Q4 25
2.4%
3.3%
Q3 25
3.4%
2.3%
Q2 25
3.5%
2.2%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Q1 24
4.4%
Cash Conversion
PRCT
PRCT
THR
THR
Q4 25
0.98×
Q3 25
0.50×
Q2 25
1.25×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Hand Pieces And Other Consumables$34.1M45%
System Sales And Rentals$27.5M36%
Other$9.8M13%
Service Revenue$5.0M7%

THR
THR

Other$73.7M50%
Transferred At Point In Time$56.1M38%
Transferred Over Time$17.5M12%

Related Comparisons